177Lu-PSMA-0057
/ Medical School of Nanjing University, Fosun Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 31, 2025
68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
(clinicaltrials.gov)
- P1/2 | N=49 | Not yet recruiting | Sponsor: Chengdu StarRay Therapeutics Co., Ltd
New P1/2 trial • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
September 22, 2023
Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer
(clinicaltrials.gov)
- P1 | N=10 | Recruiting | Sponsor: Nanjing First Hospital, Nanjing Medical University
Metastases • New P1 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1